Equity Profile

LH

Labcorp Holdings Inc.

Health CareHealth Care Services$22.7B

Jul23Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Labcorp Holdings Inc. is a leading health care company that provides laboratory services and diagnostics....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well Labcorp is managing costs and generating income.

Not available

Revenue Growth

Revenue growth will indicate the company's ability to expand its services and market share in the competitive health care landscape.

Not available

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

LH Q2-2026 Earnings Preview

Context

Company Snapshot

Labcorp Holdings Inc. is a leading health care company that provides laboratory services and diagnostics. With a market cap of $23 billion, it plays a crucial role in the health care sector, helping patients and providers make informed decisions through accurate testing and analysis.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+2.88%

Avg Stock Reaction

+1.95%

Last Quarter Recap

In Q1-2026, Labcorp reported an EPS of $4.25, exceeding estimates by 3.81%. However, the stock saw a slight decline of 0.13% the following day, indicating mixed investor sentiment.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic about Labcorp's upcoming earnings, given its history of beating EPS estimates. However, the lack of specific guidance raises uncertainty about future performance.

Bull Case

If Labcorp continues its trend of beating EPS estimates, it could signal strong operational performance and investor confidence, potentially driving the stock higher.

Bear Case

Conversely, any signs of declining testing volumes or increased costs could lead to disappointment, causing the stock to drop.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS figure for Q2-2026?

Given Labcorp's history of beating EPS estimates, this figure will be crucial for assessing the company's financial health and investor confidence.

How has testing volume changed compared to previous quarters?

Changes in testing volume can indicate shifts in demand for Labcorp's services, impacting future revenue and growth prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Labcorp's ability to maintain testing volumes despite economic pressures, as historical data suggests resilience in demand.

Supporting Evidence

Labcorp has consistently beaten EPS estimates, indicating strong management and operational efficiency.

The options market is pricing in a larger move than historical averages, suggesting that investors expect significant news.

Recent insider buying indicates confidence in the company's future performance.

Key Risk

If testing volumes show unexpected growth, it could significantly alter market perceptions and expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Labcorp can sustain its growth trajectory in a competitive environment, especially with rising costs and changing demand.

Bull Confirmed If

An EPS of $4.50 or higher would confirm strong operational performance and growth.

Bear Confirmed If

An EPS below $4.00 would raise concerns about profitability and operational efficiency.

Pre-Earnings Positioning

Options Market

Implied Move

±10.59%

Historical Avg

±4.2%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings announcement.

Options are pricing ±10.6% while LH has averaged ±4.2% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

19.1%

Calls (600)P/C Ratio: 72.71Puts (300)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Labcorp beats expectations, history suggests the stock could rise by around 1.95% on the following day, confirming strong operational health.

In-Line / Cautious

If results are in line with expectations, the stock may see limited movement, reflecting cautious investor sentiment.

Miss

A miss could lead to a decline of around 4.18%, as investors react negatively to disappointing performance.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

2 buys·0 sells

Members

House only

Est. Notional

$2,002.00–$30,000.00

disclosed dollar ranges

Most Active Members

D-MDApril McClain DelaneyRep.
2

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on testing volume trends and demand for services.
2Management's outlook on cost management and operational efficiency.
3Insights into new service offerings or technological advancements.
4Comments on market competition and Labcorp's strategic positioning.
5Any guidance on future revenue growth or EPS expectations.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Domino's Pizza, Inc.

Company Snapshot

Labcorp Holdings Inc. is a leading health care company that provides laboratory services and diagnostics....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and will show how well Labcorp is managing costs and generating income.

Not available

Revenue Growth

Revenue growth will indicate the company's ability to expand its services and market share in the competitive health care landscape.

Not available

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

LH Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+2.88%

Avg Stock Reaction

+1.95%

Last Quarter Recap

In Q1-2026, Labcorp reported an EPS of $4.25, exceeding estimates by 3.81%. However, the stock saw a slight decline of 0.13% the following day, indicating mixed investor sentiment.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic about Labcorp's upcoming earnings, given its history of beating EPS estimates. However, the lack of specific guidance raises uncertainty about future performance.

Bull Case

If Labcorp continues its trend of beating EPS estimates, it could signal strong operational performance and investor confidence, potentially driving the stock higher.

Bear Case

Conversely, any signs of declining testing volumes or increased costs could lead to disappointment, causing the stock to drop.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS figure for Q2-2026?

Given Labcorp's history of beating EPS estimates, this figure will be crucial for assessing the company's financial health and investor confidence.

How has testing volume changed compared to previous quarters?

Changes in testing volume can indicate shifts in demand for Labcorp's services, impacting future revenue and growth prospects.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Labcorp's ability to maintain testing volumes despite economic pressures, as historical data suggests resilience in demand.

Supporting Evidence

Labcorp has consistently beaten EPS estimates, indicating strong management and operational efficiency.

The options market is pricing in a larger move than historical averages, suggesting that investors expect significant news.

Recent insider buying indicates confidence in the company's future performance.

Key Risk

If testing volumes show unexpected growth, it could significantly alter market perceptions and expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Labcorp can sustain its growth trajectory in a competitive environment, especially with rising costs and changing demand.

Bull Confirmed If

An EPS of $4.50 or higher would confirm strong operational performance and growth.

Bear Confirmed If

An EPS below $4.00 would raise concerns about profitability and operational efficiency.

Pre-Earnings Positioning

Options Market

Implied Move

±10.59%

Historical Avg

±4.2%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings announcement.

Options are pricing ±10.6% while LH has averaged ±4.2% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

19.1%

Calls (600)P/C Ratio: 72.71Puts (300)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Labcorp beats expectations, history suggests the stock could rise by around 1.95% on the following day, confirming strong operational health.

In-Line / Cautious

If results are in line with expectations, the stock may see limited movement, reflecting cautious investor sentiment.

Miss

A miss could lead to a decline of around 4.18%, as investors react negatively to disappointing performance.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

2 buys·0 sells

Members

House only

Est. Notional

$2,002.00–$30,000.00

disclosed dollar ranges

Most Active Members

D-MDApril McClain DelaneyRep.
2

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on testing volume trends and demand for services.
2Management's outlook on cost management and operational efficiency.
3Insights into new service offerings or technological advancements.
4Comments on market competition and Labcorp's strategic positioning.
5Any guidance on future revenue growth or EPS expectations.